Despite long-standing efforts to control it, trachoma remainsthe leading cause of preventable blindness in the world. Accordingto the most recent estimates, some 84 million people have activetrachoma (the infectious stage) in 55 countries in which thedisease is endemic (Figure 1), and 7.6 million people have trachomatoustrichiasis, the blinding stage of this infectious disease. Trachomais a chronic keratoconjunctivitis caused by repeated reinfectionwith the ocular serotypes A, B, Ba, and C of Chlamydia trachomatis,an obligate intracellular bacterium. The infection causes amucopurulent conjunctivitis that is generally self-healing withoutsequelae.
View larger version (39K): [in this window]
[in a new window]
From Prevention of Blindness and Deafness, World Health Organization, Geneva.
This article has been cited by other articles:
Melese, M., Alemayehu, W., Lakew, T., Yi, E., House, J., Chidambaram, J. D., Zhou, Z., Cevallos, V., Ray, K., Hong, K. C., Porco, T. C., Phan, I., Zaidi, A., Gaynor, B. D., Whitcher, J. P., Lietman, T. M.
(2008). Comparison of Annual and Biannual Mass Antibiotic Administration for Elimination of Infectious Trachoma. JAMA
299: 778-784
[Abstract][Full Text]
Mabey, D., Solomon, A. W.
(2008). Mass Antibiotic Administration for Eradication of Ocular Chlamydia trachomatis. JAMA
299: 819-821
[Full Text]
Natividad, A., Holland, M. J., Rockett, K. A., Forton, J., Faal, N., Joof, H. M., Mabey, D. C.W., Bailey, R. L., Kwiatkowski, D. P.
(2008). Susceptibility to sequelae of human ocular chlamydial infection associated with allelic variation in IL10 cis-regulation. Hum Mol Genet
17: 323-329
[Abstract][Full Text]
Chidambaram, J. D., Alemayehu, W., Melese, M., Lakew, T., Yi, E., House, J., Cevallos, V., Zhou, Z., Maxey, K., Lee, D. C., Shapiro, B. L., Srinivasan, M., Porco, T., Whitcher, J. P., Gaynor, B. D., Lietman, T. M.
(2006). Effect of a Single Mass Antibiotic Distribution on the Prevalence of Infectious Trachoma. JAMA
295: 1142-1146
[Abstract][Full Text]